A股異動 | 寶鷹股份漲5.58% 控股股東由航空城集團變更為大橫琴集團
格隆匯2月20日丨寶鷹股份漲5.58%,報4.16元,總市值63億元。寶鷹股份昨日發佈公吿,控股股東珠海航空城發展集團有限公司擬向珠海大橫琴集團有限公司協議轉讓上市公司19.46%股份,交易價格為4.932元/股,較最新股價溢價25%;同時擬將自身所持及受股東古少明所託合計擁有的15.59%股份表決權,委託給大橫琴集團。交易完成後,大橫琴集團將合計擁有5.31億股股份表決權,佔總股本的35.05%,取得寶鷹股份控股權。因大橫琴集團與航空城集團同為珠海市國資委下屬企業,本次交易未導致公司實控人變更,寶鷹股份實控人仍為珠海市國資委。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.